Literature DB >> 16436934

Biological rhythm disturbances in mood disorders.

Anna Wirz-Justice1.   

Abstract

From earliest times, psychiatrists have described biological rhythm disturbances as characteristic of mood disorders. The present flourishing of circadian biology has revealed the molecular basis of 24-h rhythmicity driven by 'clock' genes, as well as the importance of zeitgebers (synchronisers). Winter depression was first modelled on regulation of animal behaviour by seasonal changes in daylength, and led to application of light as the first successful chronobiological treatment in psychiatry. Light therapy has great promise for many other disorders (e.g. sleep-wake cycle disturbances in Alzheimer's dementia, bulimia, premenstrual disorder, depression during pregnancy) and, importantly, as an adjuvant to antidepressant medication in major non-seasonal depression. The pineal hormone melatonin is also a zeitgeber for the human circadian system, in addition to possessing direct sleep-promoting effects. Chronobiology has provided efficacious non-pharmaceutical treatments for mood disorders (such as sleep deprivation or light therapy) as well as novel approaches to new drugs (e.g. agomelatine).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436934     DOI: 10.1097/01.yic.0000195660.37267.cf

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  88 in total

Review 1.  Effects of circadian disruption on mental and physical health.

Authors:  Ilia N Karatsoreos
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  Chronic treatment with a selective inhibitor of casein kinase I delta/epsilon yields cumulative phase delays in circadian rhythms.

Authors:  Jeffrey Sprouse; Linda Reynolds; Robin Kleiman; Barbara Tate; Terri A Swanson; Gary E Pickard
Journal:  Psychopharmacology (Berl)       Date:  2010-04-21       Impact factor: 4.530

Review 3.  Stress and glucocorticoid receptor transcriptional programming in time and space: Implications for the brain-gut axis.

Authors:  J W Wiley; G A Higgins; B D Athey
Journal:  Neurogastroenterol Motil       Date:  2016-01       Impact factor: 3.598

4.  Testing the role of circadian genes in conferring risk for psychiatric disorders.

Authors:  Enda M Byrne; Andrew C Heath; Pamela A F Madden; Michele L Pergadia; Ian B Hickie; Grant W Montgomery; Nicholas G Martin; Naomi R Wray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-03-29       Impact factor: 3.568

Review 5.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

6.  Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

Authors:  Robert L Gannon; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2007-08-13       Impact factor: 4.530

7.  Altered expression of circadian rhythm genes among individuals with a history of depression.

Authors:  Jean-Philippe Gouin; James Connors; Janice K Kiecolt-Glaser; Ronald Glaser; William B Malarkey; Cathie Atkinson; David Beversdorf; Ning Quan
Journal:  J Affect Disord       Date:  2010-05-14       Impact factor: 4.839

8.  Poor sleep quality increases symptoms of depression and anxiety in postpartum women.

Authors:  Michele L Okun; Roberta A Mancuso; Calvin J Hobel; Christine Dunkel Schetter; Mary Coussons-Read
Journal:  J Behav Med       Date:  2018-07-20

9.  Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.

Authors:  Shadab Ataur Rahman; Shai Marcu; Leonid Kayumov; Colin Michael Shapiro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-18       Impact factor: 5.270

10.  The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls.

Authors:  Philipp S Ritter; Carolin Marx; Natalia Lewtschenko; Steffi Pfeiffer; Karolina Leopold; Michael Bauer; Andrea Pfennig
Journal:  J Neural Transm (Vienna)       Date:  2012-08-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.